SynthesisScientific reports2026

Efficacy and safety of tepotinib in MET‑altered non‑small cell lung cancer: a meta-analysis.

Jiayi Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.